Skip to main content
. 2016 Sep 21;22(35):8050–8059. doi: 10.3748/wjg.v22.i35.8050

Figure 1.

Figure 1

Overall treatment outcome. 1Two hundred and sixty consecutive patients were treated with second generation direct acting antiviral (DAA) combinations; 14/260 patients lost to follow-up were not included in our analysis [modified intention-to-treat (mITT) analysis]. Additionally, 2 patients discontinued treatment prematurely, but achieved sustained virological response (SVR); accordingly these 2 patients also were counted as SVR12 patients.